🔎 Trials Near Me

Inicio › Neuroblastoma › Georgia

Ensayos clínicos de Neuroblastoma en Georgia

9 estudios sobre Neuroblastoma buscan participantes en Georgia.

Ciudades en Georgia

Texto oficial del estudio (inglés)

Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma

  • Children's Healthcare of Atlanta, Atlanta
Reclutando
Hasta los 17 · Todos los sexos · Actualizado el 13 nov 2026 · NCT06831552

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

  • Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
  • Memorial Health University Medical Center, Savannah
ReclutandoFase 3
Hasta los 30 · Todos los sexos · Actualizado el 30 oct 2026 · NCT06172296

Pediatric Precision Laboratory Advanced Neuroblastoma Therapy

  • Augusta University Health, Augusta
ReclutandoFase 2
Hasta los 22 · Todos los sexos · Actualizado el 4 sept 2026 · NCT02559778

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

  • Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
  • Memorial Health University Medical Center, Savannah
ReclutandoFase 3
365 Days – 30 Years · Todos los sexos · Actualizado el 25 ago 2026 · NCT03126916

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
ReclutandoFase 1/2
12 Months – 30 Years · Todos los sexos · Actualizado el 25 ago 2026 · NCT04851119

Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma

  • Augusta University Health, Augusta
ReclutandoFase 2
12 Months – 21 Years · Todos los sexos · Actualizado el 12 ago 2026 · NCT05489887

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

  • Children's Healthcare of Atlanta/Emory University School of Medicine, Atlanta
ReclutandoFase 1/2
12 Months – 30 Years · Todos los sexos · Actualizado el 19 may 2026 · NCT04901702

Neuroblastoma Biology Study

  • AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Egleston Campus, Atlanta
ReclutandoEstudio observacional
31 Days – 99 Years · Todos los sexos · Actualizado el 23 mar 2026 · NCT01587300

Allogeneic Expanded Gamma Delta T Cells With GD2 Chemoimmunotherapy in Relapsed /Refractory Neuroblastoma or Refractory/ Relapsed Osteosarcoma

  • Children's Healthcare of Atlanta, Atlanta
ReclutandoFase 1
12 Months · Todos los sexos · Actualizado el 26 dic 2025 · NCT05400603

De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.